LPS activates the NOD-like receptor protein 3 (NLRP3) inflammasome in the liver, resulting in the production of proinflammatory factors such as IL-18/1β and accelerating the NAFLD process [11, 12]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.